Fiber calculator with GLP-1 constipation overlay

GLP-1 Fiber Calculator

Constipation affects up to 24% of Wegovy patients and 7% of Zepbound patients per the FDA labels. Adequate fiber intake is the first-line dietary mitigation. This calculator computes your NASEM-based daily fiber goal, identifies the gap from your current intake, and generates a gradual increase schedule (+5 g/week per AGA guidelines) to avoid worsening GI symptoms.

Your daily fiber target

Recommended daily fiber
25 g
NASEM baseline
25 g/day
Adjusted target
25 g/day
Important tip

Increase fiber gradually by ~5 g per week and drink extra water to avoid worsening GI side effects. Jumping to a high-fiber diet too quickly can cause bloating and gas — especially problematic for GLP-1 patients already experiencing GI symptoms.

Top high-fiber foods (USDA FoodData Central)
FoodServingFiber
Black beans1 cup cooked15 g
Lentils1 cup cooked15.6 g
Chickpeas1 cup cooked12.5 g
Chia seeds2 tablespoons9.8 g
Avocado1 whole10 g
Raspberries1 cup8 g
Pear1 medium5.5 g
Broccoli1 cup cooked5.1 g
Oatmeal1 cup cooked4 g
Almonds1 oz (23 nuts)3.5 g

How the calculator works

  • NASEM Adequate Intake (2005) [1]: The base recommendation comes from the National Academies DRI for fiber — 38 g/day for men 19-50, 30 g/day for men 51+, 25 g/day for women 19-50, 21 g/day for women 51+.
  • USDA Dietary Guidelines (2020-2025) [2]: Alternatively expressed as 14 g per 1,000 kcal consumed.
  • GLP-1 constipation adjustment: If you are on a GLP-1 agonist AND experiencing constipation, the calculator adds +5 g/day to push toward the upper end of your age-sex range. This is first-line dietary management per AGA 2021 guidelines [6].
  • Gradual increase schedule: The AGA recommends increasing fiber by approximately 5 g per week [6] to minimize bloating and gas. The calculator generates a week-by-week schedule from your current intake to your target.

Why GLP-1 patients need fiber

GLP-1 receptor agonists slow gastric emptying and reduce gut motility, which directly contributes to constipation [3][4]. Reduced food intake also means less dietary fiber if patients are not specifically targeting high-fiber foods. The combination of slower transit, lower bulk, and reduced fluid intake makes constipation one of the most persistent GLP-1 side effects.

Fiber + adequate water is the first-line management strategy before pharmacological laxatives. Soluble fiber (oats, beans, psyllium) adds bulk and softness to stool; insoluble fiber (bran, vegetables) stimulates peristalsis.

Important: increase gradually

Jumping from a low-fiber diet directly to a high-fiber target can cause bloating, gas, and abdominal discomfort — which are especially problematic for GLP-1 patients already experiencing GI side effects. The AGA recommends increasing fiber by about 5 g per week [6]. This calculator generates that schedule automatically.

Important disclaimer

This calculator is for educational purposes only and does not constitute medical advice. Patients with inflammatory bowel disease, bowel obstruction, or conditions requiring a low-fiber diet should consult their gastroenterologist before increasing fiber intake. If constipation persists despite adequate fiber and water, contact your prescribing clinician.

Related tools and research

References

  1. 1.Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). National Academies Press. 2005. https://nap.nationalacademies.org/catalog/10490/dietary-reference-intakes-for-energy-carbohydrate-fiber-fat-fatty-acids-cholesterol-protein-and-amino-acids
  2. 2.U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th Edition. DietaryGuidelines.gov. 2020. https://www.dietaryguidelines.gov/resources/2020-2025-dietary-guidelines-online-materials
  3. 3.Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use — Prescribing Information. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
  4. 4.Eli Lilly and Company. Zepbound (tirzepatide) injection, for subcutaneous use — Prescribing Information. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s000lbl.pdf
  5. 5.Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020. PMID: 31945360.
  6. 6.AGA Clinical Practice Guidelines Committee. AGA Clinical Practice Guideline on the Role of Diet and Lifestyle in the Management of Chronic Constipation. Am J Gastroenterol. 2021. PMID: 34404067.